Question 1

How much would I have if I DCA'd $100/week into TRLV for 5 years?

Accepted Answer

Dollar cost averaging $100 per week into TRLV for 5 years (261 purchases) would have resulted in a total investment of $26,100 and a current value of $38,033, a return of 46%. Using Enhanced DCA, which concentrates buys during dips, the same $100/week base deployed $65,108 and grew to $109,098 — a 68% return.

Question 2

What is the best DCA strategy for TRLV?

Accepted Answer

Backtesting shows Enhanced DCA — which increases buy amounts during market dips and reduces or skips buys when TRLV is overextended — outperformed standard weekly DCA by 22% over 5 years. The enhanced strategy achieved a 68% return vs 46% for standard DCA.

Question 3

What would $100/week into TRLV be worth after 3 years?

Accepted Answer

Investing $100 per week into TRLV for 3 years (157 purchases, $15,700 total) would have grown to $25,177 — a 60% return. Enhanced DCA over the same period returned 119%.

Question 4

Is DCA into TRLV worth it?

Accepted Answer

Based on a 5-year backtest, DCA into TRLV returned 46% with standard weekly purchases. An intelligent DCA strategy that buys more during dips returned 68% over the same period — a 22% gain in return, while deploying more capital.

Question 5

How many shares of TRLV would I have after DCA for 5 years?

Accepted Answer

Dollar cost averaging $100/week into TRLV for 5 years would result in approximately 3564 shares with a standard DCA approach (avg entry $7). Enhanced DCA targeting dips results in 10225 shares at an average entry of $6.

Question 6

How does TRLV DCA compare to the S&P 500?

Accepted Answer

Enhanced DCA into TRLV returned 68% over the past 5 years. The S&P 500 (SPY) returned approximately 53% over the same period. TRLV's performance reflects its volatility as a healthcare asset. Enhanced DCA outperformed standard DCA by 22%, demonstrating the value of intelligent entry timing during market dips.

Question 7

What is the risk of dollar cost averaging into TRLV?

Accepted Answer

Past backtest performance does not guarantee future results. TRLV is a healthcare asset whose price can fall as well as rise. While DCA reduces timing risk by spreading purchases over time, losses are still possible if the price declines significantly. Always invest within your risk tolerance and consider your overall portfolio diversification.

Question 8

What is the Trulieve Cannabis Corp. dollar cost averaging strategy?

Accepted Answer

Standard DCA invests a fixed amount ($100/week or $433/month) into TRLV at regular intervals. Enhanced DCA improves on this by using RSI (Relative Strength Index) signals to increase buy amounts during market dips (oversold conditions) and reduce or skip purchases when the stock is overextended. Over the 5-year backtest, this timing approach has delivered 22% higher returns than standard DCA while deploying more total capital into TRLV.

Period	Standard DCA	Enhanced DCA	Alpha
1-Year	36%	78%	+43%
3-Year	60%	119%	+59%
5-Year	46%	68%	+22%

TRLV DCA Backtest — Dollar Cost Averaging Results

TRLV DCA Results: Key Findings

Alpha you missed while unsubscribed

Dollar cost averaging into TRLV — backtest results

Buying the dips for Trulieve Cannabis Corp.